http://pr.gaeatimes.com Fri, 16 Dec 2011 05:00:00 +0000 http://wordpress.org/?v=2.7.1 en hourly 1 http://pr.gaeatimes.com/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-54941/ http://pr.gaeatimes.com/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-54941/#comments Fri, 16 Dec 2011 05:00:00 +0000 Thrombogenics http://pr.gaeatimes.com/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-54941/ Source article  : ThromboGenics and BioInvent Complete Enrollment of Phase IIb Trial With TB-402 Ahead of Schedule.]]> http://pr.gaeatimes.com/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-54941/feed/ http://pr.gaeatimes.com/amsterdam-molecular-therapeutics-announces-negative-equity-position-54868/ http://pr.gaeatimes.com/amsterdam-molecular-therapeutics-announces-negative-equity-position-54868/#comments Thu, 15 Dec 2011 05:00:00 +0000 Amsterdam Molecular Therapeutics amt B.v http://pr.gaeatimes.com/amsterdam-molecular-therapeutics-announces-negative-equity-position-54868/ Read the original article on Gaea Times at : Amsterdam Molecular Therapeutics Announces Negative Equity Position.]]> http://pr.gaeatimes.com/amsterdam-molecular-therapeutics-announces-negative-equity-position-54868/feed/ http://pr.gaeatimes.com/reprocell-licensed-commercialization-right-on-human-ips-cell-derived-hepatocytes-expected-launch-in-q2-2012-54873/ http://pr.gaeatimes.com/reprocell-licensed-commercialization-right-on-human-ips-cell-derived-hepatocytes-expected-launch-in-q2-2012-54873/#comments Thu, 15 Dec 2011 05:00:00 +0000 Reprocell Inc. http://pr.gaeatimes.com/reprocell-licensed-commercialization-right-on-human-ips-cell-derived-hepatocytes-expected-launch-in-q2-2012-54873/ Original article  : ReproCELL Licensed Commercialization Right on Human iPS Cell Derived Hepatocytes - Expected Launch in Q2 2012.]]> http://pr.gaeatimes.com/reprocell-licensed-commercialization-right-on-human-ips-cell-derived-hepatocytes-expected-launch-in-q2-2012-54873/feed/ http://pr.gaeatimes.com/world%e2%80%99s-first-curvetm-image-guided-surgery-system-now-operating-in-germany-54886/ http://pr.gaeatimes.com/world%e2%80%99s-first-curvetm-image-guided-surgery-system-now-operating-in-germany-54886/#comments Thu, 15 Dec 2011 05:00:00 +0000 Brainlab Ag http://pr.gaeatimes.com/world%e2%80%99s-first-curvetm-image-guided-surgery-system-now-operating-in-germany-54886/ Original article  : World’s First Curve(TM) Image Guided Surgery System Now Operating in Germany.]]> http://pr.gaeatimes.com/world%e2%80%99s-first-curvetm-image-guided-surgery-system-now-operating-in-germany-54886/feed/ http://pr.gaeatimes.com/enlight-biosciences-forms-new-partnerships-with-astrazeneca-and-novo-nordisk-54899/ http://pr.gaeatimes.com/enlight-biosciences-forms-new-partnerships-with-astrazeneca-and-novo-nordisk-54899/#comments Thu, 15 Dec 2011 05:00:00 +0000 Enlight Biosciences Llc http://pr.gaeatimes.com/enlight-biosciences-forms-new-partnerships-with-astrazeneca-and-novo-nordisk-54899/ Source  : Gaea News Network.]]> http://pr.gaeatimes.com/enlight-biosciences-forms-new-partnerships-with-astrazeneca-and-novo-nordisk-54899/feed/ http://pr.gaeatimes.com/correction-brainlab-ag-world%e2%80%99s-first-curvetm-image-guided-surgery-system-now-operating-in-germany-54935/ http://pr.gaeatimes.com/correction-brainlab-ag-world%e2%80%99s-first-curvetm-image-guided-surgery-system-now-operating-in-germany-54935/#comments Thu, 15 Dec 2011 05:00:00 +0000 Brainlab Ag http://pr.gaeatimes.com/correction-brainlab-ag-world%e2%80%99s-first-curvetm-image-guided-surgery-system-now-operating-in-germany-54935/ Original source on Gaea Times at : CORRECTION - Brainlab AG: World’s First Curve(TM) Image Guided Surgery System Now Operating in Germany.]]> http://pr.gaeatimes.com/correction-brainlab-ag-world%e2%80%99s-first-curvetm-image-guided-surgery-system-now-operating-in-germany-54935/feed/ http://pr.gaeatimes.com/a-new-international-congress-on-regenerative-medicine-held-with-great-success-by-cryo-save-in-bosnia-54794/ http://pr.gaeatimes.com/a-new-international-congress-on-regenerative-medicine-held-with-great-success-by-cryo-save-in-bosnia-54794/#comments Wed, 14 Dec 2011 05:00:00 +0000 Cryo-save Ag http://pr.gaeatimes.com/a-new-international-congress-on-regenerative-medicine-held-with-great-success-by-cryo-save-in-bosnia-54794/ Read the original article on Gaea Times at : A New International Congress on Regenerative Medicine Held With Great Success by Cryo-Save in Bosnia.]]> http://pr.gaeatimes.com/a-new-international-congress-on-regenerative-medicine-held-with-great-success-by-cryo-save-in-bosnia-54794/feed/ http://pr.gaeatimes.com/reportsnreports-aseptic-packaging-to-2015-54811/ http://pr.gaeatimes.com/reportsnreports-aseptic-packaging-to-2015-54811/#comments Wed, 14 Dec 2011 05:00:00 +0000 Reportsnreports http://pr.gaeatimes.com/reportsnreports-aseptic-packaging-to-2015-54811/ here.]]> http://pr.gaeatimes.com/reportsnreports-aseptic-packaging-to-2015-54811/feed/ http://pr.gaeatimes.com/no-european-scientists-left-by-2020-54822/ http://pr.gaeatimes.com/no-european-scientists-left-by-2020-54822/#comments Wed, 14 Dec 2011 05:00:00 +0000 Eun Partnership Aisbl http://pr.gaeatimes.com/no-european-scientists-left-by-2020-54822/ No European Scientists Left by 2020?.]]> http://pr.gaeatimes.com/no-european-scientists-left-by-2020-54822/feed/ http://pr.gaeatimes.com/visongains-report-predicts-that-medical-biobanking-market-will-reach-191-bllion-dollars-in-2015-54826/ http://pr.gaeatimes.com/visongains-report-predicts-that-medical-biobanking-market-will-reach-191-bllion-dollars-in-2015-54826/#comments Wed, 14 Dec 2011 05:00:00 +0000 Visiongain http://pr.gaeatimes.com/visongains-report-predicts-that-medical-biobanking-market-will-reach-191-bllion-dollars-in-2015-54826/ Visongain’s Report Predicts That Medical Biobanking Market Will Reach 19.1 Bllion Dollars in 2015.]]> http://pr.gaeatimes.com/visongains-report-predicts-that-medical-biobanking-market-will-reach-191-bllion-dollars-in-2015-54826/feed/ http://pr.gaeatimes.com/bright-light-therapy-via-ear-canals-improved-reaction-times-of-top-athletes-in-a-placebo-controlled-psycho-motoric-study-54832/ http://pr.gaeatimes.com/bright-light-therapy-via-ear-canals-improved-reaction-times-of-top-athletes-in-a-placebo-controlled-psycho-motoric-study-54832/#comments Wed, 14 Dec 2011 05:00:00 +0000 Valkee http://pr.gaeatimes.com/bright-light-therapy-via-ear-canals-improved-reaction-times-of-top-athletes-in-a-placebo-controlled-psycho-motoric-study-54832/ Gaea News Network.]]> http://pr.gaeatimes.com/bright-light-therapy-via-ear-canals-improved-reaction-times-of-top-athletes-in-a-placebo-controlled-psycho-motoric-study-54832/feed/ http://pr.gaeatimes.com/elsevier-and-federation-of-biochemical-societies-launch-new-journal-febs-open-bio-54840/ http://pr.gaeatimes.com/elsevier-and-federation-of-biochemical-societies-launch-new-journal-febs-open-bio-54840/#comments Wed, 14 Dec 2011 05:00:00 +0000 Elsevier http://pr.gaeatimes.com/elsevier-and-federation-of-biochemical-societies-launch-new-journal-febs-open-bio-54840/ Elsevier and Federation of Biochemical Societies Launch New Journal: FEBS Open Bio.]]> http://pr.gaeatimes.com/elsevier-and-federation-of-biochemical-societies-launch-new-journal-febs-open-bio-54840/feed/ http://pr.gaeatimes.com/the-pharmabiotic-research-institute-pri-is-preparing-to-publish-its-first-works-on-the-therapeutic-and-medicinal-potential-of-probiotics-54722/ http://pr.gaeatimes.com/the-pharmabiotic-research-institute-pri-is-preparing-to-publish-its-first-works-on-the-therapeutic-and-medicinal-potential-of-probiotics-54722/#comments Tue, 13 Dec 2011 05:00:00 +0000 The Pharmabiotic Research Institute pri http://pr.gaeatimes.com/the-pharmabiotic-research-institute-pri-is-preparing-to-publish-its-first-works-on-the-therapeutic-and-medicinal-potential-of-probiotics-54722/ Original article on Gaea Times at  : The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics.]]> http://pr.gaeatimes.com/the-pharmabiotic-research-institute-pri-is-preparing-to-publish-its-first-works-on-the-therapeutic-and-medicinal-potential-of-probiotics-54722/feed/ http://pr.gaeatimes.com/merck-serono-helps-eliminate-schistosomiasis-in-africa-54730/ http://pr.gaeatimes.com/merck-serono-helps-eliminate-schistosomiasis-in-africa-54730/#comments Tue, 13 Dec 2011 05:00:00 +0000 Merck Serono S A http://pr.gaeatimes.com/merck-serono-helps-eliminate-schistosomiasis-in-africa-54730/ Original article on Gaea Times at  : Merck Serono Helps Eliminate Schistosomiasis in Africa.]]> http://pr.gaeatimes.com/merck-serono-helps-eliminate-schistosomiasis-in-africa-54730/feed/ http://pr.gaeatimes.com/pharmalink-ab-gains-exclusive-licence-to-archimedes-pharmas-targit%c2%ae-technology-for-nefecon%c2%ae-pl-56-program-54731/ http://pr.gaeatimes.com/pharmalink-ab-gains-exclusive-licence-to-archimedes-pharmas-targit%c2%ae-technology-for-nefecon%c2%ae-pl-56-program-54731/#comments Tue, 13 Dec 2011 05:00:00 +0000 Pharmalink Ab http://pr.gaeatimes.com/pharmalink-ab-gains-exclusive-licence-to-archimedes-pharmas-targit%c2%ae-technology-for-nefecon%c2%ae-pl-56-program-54731/ Pharmalink AB Gains Exclusive Licence to Archimedes Pharma’s TARGIT® Technology for Nefecon® (PL-56) Program.]]> http://pr.gaeatimes.com/pharmalink-ab-gains-exclusive-licence-to-archimedes-pharmas-targit%c2%ae-technology-for-nefecon%c2%ae-pl-56-program-54731/feed/ http://pr.gaeatimes.com/pieris-presents-preclinical-data-for-prs-080-hepcidin-antagonist-anticalinr-program-at-ash-annual-meeting-54742/ http://pr.gaeatimes.com/pieris-presents-preclinical-data-for-prs-080-hepcidin-antagonist-anticalinr-program-at-ash-annual-meeting-54742/#comments Tue, 13 Dec 2011 05:00:00 +0000 Pieris Ag http://pr.gaeatimes.com/pieris-presents-preclinical-data-for-prs-080-hepcidin-antagonist-anticalinr-program-at-ash-annual-meeting-54742/ Read this article on Gaea Times at : Pieris Presents Preclinical Data for PRS-080 Hepcidin Antagonist Anticalin(R) Program at ASH Annual Meeting.]]> http://pr.gaeatimes.com/pieris-presents-preclinical-data-for-prs-080-hepcidin-antagonist-anticalinr-program-at-ash-annual-meeting-54742/feed/ http://pr.gaeatimes.com/sweet-success-for-hosmac-india-pvt-ltd-at-et-now-indiamart-leaders-of-tomorrow-awards-2011-54747/ http://pr.gaeatimes.com/sweet-success-for-hosmac-india-pvt-ltd-at-et-now-indiamart-leaders-of-tomorrow-awards-2011-54747/#comments Tue, 13 Dec 2011 05:00:00 +0000 Indiamart.com http://pr.gaeatimes.com/sweet-success-for-hosmac-india-pvt-ltd-at-et-now-indiamart-leaders-of-tomorrow-awards-2011-54747/ Sweet Success for Hosmac India Pvt. Ltd. at ET NOW-IndiaMART Leaders of Tomorrow Awards 2011.]]> http://pr.gaeatimes.com/sweet-success-for-hosmac-india-pvt-ltd-at-et-now-indiamart-leaders-of-tomorrow-awards-2011-54747/feed/ http://pr.gaeatimes.com/chandler-chicco-companies-acquires-haas-health-partner-public-relations-and-sancom-creative-communication-solutions-creating-unrivalled-healthcare-communication-capability-in-germany-54778/ http://pr.gaeatimes.com/chandler-chicco-companies-acquires-haas-health-partner-public-relations-and-sancom-creative-communication-solutions-creating-unrivalled-healthcare-communication-capability-in-germany-54778/#comments Tue, 13 Dec 2011 05:00:00 +0000 Chandler Chicco Companies ccc http://pr.gaeatimes.com/chandler-chicco-companies-acquires-haas-health-partner-public-relations-and-sancom-creative-communication-solutions-creating-unrivalled-healthcare-communication-capability-in-germany-54778/ Read : Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany.]]> http://pr.gaeatimes.com/chandler-chicco-companies-acquires-haas-health-partner-public-relations-and-sancom-creative-communication-solutions-creating-unrivalled-healthcare-communication-capability-in-germany-54778/feed/ http://pr.gaeatimes.com/molecular-imaging-inc-enters-relationship-with-dana-farber-cancer-institute-to-expand-luciferase-reporter-cancer-cell-lines-for-preclinical-in-vivo-imaging-54783/ http://pr.gaeatimes.com/molecular-imaging-inc-enters-relationship-with-dana-farber-cancer-institute-to-expand-luciferase-reporter-cancer-cell-lines-for-preclinical-in-vivo-imaging-54783/#comments Tue, 13 Dec 2011 05:00:00 +0000 Molecular Imaging Inc. http://pr.gaeatimes.com/molecular-imaging-inc-enters-relationship-with-dana-farber-cancer-institute-to-expand-luciferase-reporter-cancer-cell-lines-for-preclinical-in-vivo-imaging-54783/ Source article  : Molecular Imaging, Inc. Enters Relationship with Dana-Farber Cancer Institute to Expand Luciferase-reporter Cancer Cell Lines for Preclinical in vivo Imaging.]]> http://pr.gaeatimes.com/molecular-imaging-inc-enters-relationship-with-dana-farber-cancer-institute-to-expand-luciferase-reporter-cancer-cell-lines-for-preclinical-in-vivo-imaging-54783/feed/ http://pr.gaeatimes.com/edoxaban-significantly-reduces-risk-of-venous-thromboembolism-by-half-compared-to-enoxaparin-in-japanese-and-taiwanese-patients-following-knee-or-hip-arthroplasty-surgery-54715/ http://pr.gaeatimes.com/edoxaban-significantly-reduces-risk-of-venous-thromboembolism-by-half-compared-to-enoxaparin-in-japanese-and-taiwanese-patients-following-knee-or-hip-arthroplasty-surgery-54715/#comments Tue, 13 Dec 2011 05:00:00 +0000 Daiichi Sankyo Company Limited http://pr.gaeatimes.com/edoxaban-significantly-reduces-risk-of-venous-thromboembolism-by-half-compared-to-enoxaparin-in-japanese-and-taiwanese-patients-following-knee-or-hip-arthroplasty-surgery-54715/ Read the original article: here.]]> http://pr.gaeatimes.com/edoxaban-significantly-reduces-risk-of-venous-thromboembolism-by-half-compared-to-enoxaparin-in-japanese-and-taiwanese-patients-following-knee-or-hip-arthroplasty-surgery-54715/feed/ http://pr.gaeatimes.com/researchmoz-biosimilarfollow-on-biologics-market-report-forecast-a-focus-on-the-us-2011-2020-54653/ http://pr.gaeatimes.com/researchmoz-biosimilarfollow-on-biologics-market-report-forecast-a-focus-on-the-us-2011-2020-54653/#comments Mon, 12 Dec 2011 05:00:00 +0000 Researchmoz http://pr.gaeatimes.com/researchmoz-biosimilarfollow-on-biologics-market-report-forecast-a-focus-on-the-us-2011-2020-54653/ Gaea News Network.]]> http://pr.gaeatimes.com/researchmoz-biosimilarfollow-on-biologics-market-report-forecast-a-focus-on-the-us-2011-2020-54653/feed/ http://pr.gaeatimes.com/abbott-and-reata-pharmaceuticals-announce-agreement-to-develop-and-commercialize-next-generation-antioxidant-inflammation-modulators-54667/ http://pr.gaeatimes.com/abbott-and-reata-pharmaceuticals-announce-agreement-to-develop-and-commercialize-next-generation-antioxidant-inflammation-modulators-54667/#comments Mon, 12 Dec 2011 05:00:00 +0000 Abbott http://pr.gaeatimes.com/abbott-and-reata-pharmaceuticals-announce-agreement-to-develop-and-commercialize-next-generation-antioxidant-inflammation-modulators-54667/ Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Next-Generation Antioxidant Inflammation Modulators.]]> http://pr.gaeatimes.com/abbott-and-reata-pharmaceuticals-announce-agreement-to-develop-and-commercialize-next-generation-antioxidant-inflammation-modulators-54667/feed/ http://pr.gaeatimes.com/mexican-state-of-tamaulipas-starts-training-doctors-in-sangui-wound-management-54674/ http://pr.gaeatimes.com/mexican-state-of-tamaulipas-starts-training-doctors-in-sangui-wound-management-54674/#comments Mon, 12 Dec 2011 05:00:00 +0000 Sangui Bio Tech International Inc. http://pr.gaeatimes.com/mexican-state-of-tamaulipas-starts-training-doctors-in-sangui-wound-management-54674/ Original article on : Mexican State of Tamaulipas Starts Training Doctors in Sangui Wound Management.]]> http://pr.gaeatimes.com/mexican-state-of-tamaulipas-starts-training-doctors-in-sangui-wound-management-54674/feed/ http://pr.gaeatimes.com/change-pain%c2%ae-initiative-patients-and-physicians-benefit-from-multidisciplinary-approach-in-chronic-pain-management-54676/ http://pr.gaeatimes.com/change-pain%c2%ae-initiative-patients-and-physicians-benefit-from-multidisciplinary-approach-in-chronic-pain-management-54676/#comments Mon, 12 Dec 2011 05:00:00 +0000 Grunenthal Gmbh http://pr.gaeatimes.com/change-pain%c2%ae-initiative-patients-and-physicians-benefit-from-multidisciplinary-approach-in-chronic-pain-management-54676/ Source article  : CHANGE PAIN® Initiative: Patients and Physicians Benefit From Multidisciplinary Approach in Chronic Pain Management.]]> http://pr.gaeatimes.com/change-pain%c2%ae-initiative-patients-and-physicians-benefit-from-multidisciplinary-approach-in-chronic-pain-management-54676/feed/ http://pr.gaeatimes.com/nonin-medical-announces-the-european-launch-of-equanox-advance%e2%84%a2-neonatalpediatric-sensor-for-regional-oximetry-at-pga-conference-54705/ http://pr.gaeatimes.com/nonin-medical-announces-the-european-launch-of-equanox-advance%e2%84%a2-neonatalpediatric-sensor-for-regional-oximetry-at-pga-conference-54705/#comments Mon, 12 Dec 2011 05:00:00 +0000 Nonin Medical Inc. http://pr.gaeatimes.com/nonin-medical-announces-the-european-launch-of-equanox-advance%e2%84%a2-neonatalpediatric-sensor-for-regional-oximetry-at-pga-conference-54705/ Nonin Medical Announces the European Launch of EQUANOX Advance™ Neonatal/Pediatric Sensor for Regional Oximetry at PGA Conference.]]> http://pr.gaeatimes.com/nonin-medical-announces-the-european-launch-of-equanox-advance%e2%84%a2-neonatalpediatric-sensor-for-regional-oximetry-at-pga-conference-54705/feed/ http://pr.gaeatimes.com/cas-and-infochem-enter-into-long-term-collaboration-in-cheminformatics-54711/ http://pr.gaeatimes.com/cas-and-infochem-enter-into-long-term-collaboration-in-cheminformatics-54711/#comments Mon, 12 Dec 2011 05:00:00 +0000 Chemical Abstracts Service cas http://pr.gaeatimes.com/cas-and-infochem-enter-into-long-term-collaboration-in-cheminformatics-54711/ CAS and InfoChem Enter Into Long Term Collaboration in ChemInformatics.]]> http://pr.gaeatimes.com/cas-and-infochem-enter-into-long-term-collaboration-in-cheminformatics-54711/feed/ http://pr.gaeatimes.com/landmark-vista-trial-shows-significant-long-term-overall-survival-benefit-of-velcade%c2%ae-bortezomib-in-patients-with-previously-untreated-multiple-myeloma-54712/ http://pr.gaeatimes.com/landmark-vista-trial-shows-significant-long-term-overall-survival-benefit-of-velcade%c2%ae-bortezomib-in-patients-with-previously-untreated-multiple-myeloma-54712/#comments Mon, 12 Dec 2011 05:00:00 +0000 Janssen Pharmaceuticals Nv http://pr.gaeatimes.com/landmark-vista-trial-shows-significant-long-term-overall-survival-benefit-of-velcade%c2%ae-bortezomib-in-patients-with-previously-untreated-multiple-myeloma-54712/ Landmark VISTA Trial Shows Significant Long-Term Overall Survival Benefit of VELCADE® (Bortezomib) in Patients With Previously Untreated Multiple Myeloma.]]> http://pr.gaeatimes.com/landmark-vista-trial-shows-significant-long-term-overall-survival-benefit-of-velcade%c2%ae-bortezomib-in-patients-with-previously-untreated-multiple-myeloma-54712/feed/ http://pr.gaeatimes.com/elsevier-and-lipid-maps-launch-lipid-structures-app-on-sciverse-applications-54623/ http://pr.gaeatimes.com/elsevier-and-lipid-maps-launch-lipid-structures-app-on-sciverse-applications-54623/#comments Fri, 09 Dec 2011 05:00:00 +0000 Elsevier http://pr.gaeatimes.com/elsevier-and-lipid-maps-launch-lipid-structures-app-on-sciverse-applications-54623/ Read more : Elsevier and LIPID MAPS Launch Lipid Structures App on SciVerse Applications.]]> http://pr.gaeatimes.com/elsevier-and-lipid-maps-launch-lipid-structures-app-on-sciverse-applications-54623/feed/ http://pr.gaeatimes.com/marketsandmarkets-chronic-lymphocytic-leukemia-therapeutics-market-worth-22-billion-by-2020-54547/ http://pr.gaeatimes.com/marketsandmarkets-chronic-lymphocytic-leukemia-therapeutics-market-worth-22-billion-by-2020-54547/#comments Thu, 08 Dec 2011 05:00:00 +0000 Marketsandmarkets http://pr.gaeatimes.com/marketsandmarkets-chronic-lymphocytic-leukemia-therapeutics-market-worth-22-billion-by-2020-54547/ MarketsandMarkets: Chronic Lymphocytic Leukemia Therapeutics Market Worth $2.2 Billion by 2020.]]> http://pr.gaeatimes.com/marketsandmarkets-chronic-lymphocytic-leukemia-therapeutics-market-worth-22-billion-by-2020-54547/feed/ http://pr.gaeatimes.com/shire-reports-positive-phase-ii-results-for-investigative-use-of-vyvanse%c2%ae-lisdexamfetamine-dimesylate-capsules-cii-54552/ http://pr.gaeatimes.com/shire-reports-positive-phase-ii-results-for-investigative-use-of-vyvanse%c2%ae-lisdexamfetamine-dimesylate-capsules-cii-54552/#comments Thu, 08 Dec 2011 05:00:00 +0000 Shire Plc http://pr.gaeatimes.com/shire-reports-positive-phase-ii-results-for-investigative-use-of-vyvanse%c2%ae-lisdexamfetamine-dimesylate-capsules-cii-54552/ Source  : Shire Reports Positive Phase II Results for Investigative Use of Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII).]]> http://pr.gaeatimes.com/shire-reports-positive-phase-ii-results-for-investigative-use-of-vyvanse%c2%ae-lisdexamfetamine-dimesylate-capsules-cii-54552/feed/